The Mercer consulting group told the Journal that a number of employers have had to find alternative suppliers for tests in recent weeks because they haven’t been able to secure bulk orders as demand increases.
“We have clinical vendors who can’t fill current orders with current clients,” Sandy Goldstein, a consultant at the firm, told the Journal.
CVS and Walgreens have both put limits on the number of at-home tests customers can purchase.
A Walgreens spokesperson told the Journal the company is working with test manufacturers to keep up with demand for workplace testing and that the company is filling bulk orders for tests “based on supply and availability.”
CVS declined to comment to the Journal about the availability of tests for employers.
Mara Aspinall, co-founder of a diagnostics program at Arizona State University, told the Journal “We do not have enough capacity and supply of rapid antigen tests to meet the onslaught of demand.”
Read the full article here.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.